New Cancer Drug Hits the Mark

by Medindia Content Team on  March 18, 2005 at 5:59 PM General Health News   - G J E 4
New Cancer Drug Hits the Mark
A new cancer drug is being hailed by researchers for its ability to target cancer cells and keep them from multiplying.

The drug being called ON01910 works by interfering with a molecule known as Plk1, which cancer cells need in order to divide and multiply. This molecule is found in higher numbers in cancerous tumors, and people with poorer cancer survival rates tend to have especially high amounts.

The drug was tested on 94 different types of human cancers in the laboratory both individually and in combination with other cancer drugs. The drug was able to inhibit cell division and thus hasten the death of the cancerous cells. It also appeared to be safe.

The drug is being investigated by researchers from different parts of the world who are testing the drug in up to 56 cancer patients with advanced or terminal disease to see how it works in people.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

View All